跳至主要内容
临床试验/ACTRN12623001140640
ACTRN12623001140640尚未招募Unknown

Evaluation of a Standardised ClinicAl Pathway on Equity and patient outcomes in Cardiogenic Shock: The ESCAPE-CS Trial

niversity of Sydney0 个研究点目标入组 200 人开始时间: 2023年11月3日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Inpatients at least 18 years of age at any location within a participating centre.
  • 2. Diagnosed with CS, defined as:
  • a. ST elevation myocardial infarction (STEMI) OR current/recent (within 12 months) evidence of left ventricular dysfunction
  • b. At least 2 of:
  • i. systolic blood pressure less than 90mmHg;
  • ii. use of an inotrope or vasopressor to maintain systolic blood pressure greater than, or equal to, 90mmHg
  • iii. serum lactate greater than 3mmol/L.

排除标准

  • 1. Terminal non-cardiac condition or advanced care directive rendering advanced cardiac and/or life support therapies inappropriate
  • 2. Inpatients being managed with palliative intent
  • 3. Evidence of established anoxic brain injury
  • 4. Established non-cardiac cause of shock (eg. sepsis, haemorrhagic shock, anaphylactic shock).
  • 5. Transferred from a non-participating institution with an established CS diagnosis.
  • 6. Out-of-hospital cardiac arrest with ongoing cardiopulmonary resuscitation (including ECMO-CPR).

研究者

相似试验